Member Info for Timster

@PL75 he just said that on sky currently lab in a van, but working with other manufacturers to ramp up production so mass testing can be achieved in the home

And it's an antibody test which as most think on this forum are pretty pointless

ANTIBODY test

It's this morning's RNS copy and paste ??? Not sure what you mean?

Great news today, now all we need is clinical validation. BAMS should be first and I think commentary in today's RNS suggests that we will fly through the LFT validation.

Authorities around the world are now looking to carry-out frequent mass testing to identify the most infectious people promptly in order to reduce infection rates and combat the coronavirus pandemic. That requires a highly specific test to minimize false positives which would otherwise overwhelm healthcare systems. The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements

Best thing today was all the covidiot twat derampers moved on fairly quickly....

top right just above the post a message button there is a green tab "switch to thread view"

dont talk ****** :

we are CONFIDENT of meeting and EXCEEDING the clinical performance requirements for identifying the most infectious people.

thats best in class not just good enough

The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people.

Matt han**** stated yesterday when new tests come on line they will deploy them. NO boats have been missed!

This line from the RNS tells you all you need to know about Avacta's true game changing test:
The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people.

i would imagine they'll be a directors talk interview later which will be interesting and I'm sure as they always do add a bit more information around the RNS

funny still seeing the basher trying their hardest?

one question, why would we need two manufacturing partners and still be seeking more global partners for a failed test?

Sounds like Sir Al is 100% sure validation is a done deal:

Authorities around the world are now looking to carry-out frequent mass testing to identify the most infectious people promptly in order to reduce infection rates and combat the coronavirus pandemic. That requires a highly specific test to minimize false positives which would otherwise overwhelm healthcare systems. The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people.

The issue is we need 100's of millions of these tests hence the comment below:

Manufacturing capacity is therefore the key challenge that has to be met in achieving widespread roll-out of Avacta's saliva-based rapid antigen test. We therefore continue to actively seek additional manufacturing partners globally to be able to provide the volume of tests that will be required in the UK and elsewhere. I look forward to updating the market on progress in that regard, and will keep the market informed on the key next steps of clinical validation and regulatory approval."

Authorities around the world are now looking to carry-out frequent mass testing to identify the most infectious people promptly in order to reduce infection rates and combat the coronavirus pandemic. That requires a highly specific test to minimize false positives which would otherwise overwhelm healthcare systems. The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people.

MASSIVE

Can't see your post always but guess you were congratulating sir Al...

BAMS - in validation phase 6 weeks (so must be close)
LFD - In validation phase 4 weeks. mologic antibody test (the pointless one) took four and a half weeks to be validated by LTSM

we are close the government know it too...

It's just a green box like all your other posts, let me guess though, you were moaning?

That useless was meant for the medusa antibody test.

Roche looks useful. With 40 billion plus tests required we'll need a fair few suppliers

Useless

Where did all these twat covidiots come from?

Clues in the name

he's probably talking about Mologic .... ;)

oh wait that's not being evaluated by the government on the CONDOR program.

maybe he's talking about antibody testing that must be it..